Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01431612
Other study ID # Esmolol study
Secondary ID
Status Completed
Phase Phase 1/Phase 2
First received September 6, 2011
Last updated September 7, 2011
Start date November 2008
Est. completion date October 2010

Study information

Verified date September 2011
Source Sodertalje Hospital
Contact n/a
Is FDA regulated No
Health authority China: Food and Drug Administration
Study type Interventional

Clinical Trial Summary

The aim this study was to examine to what degree the slow turnover of lactated Ringer's solution during anesthesia and surgery can be prevented by infusing esmolol (a ß1-receptor blocker) or phenylephrine in patients undergoing laparoscopic gynecological surgery performed under intravenous anesthesia.


Description:

INTRODUCTION The renal clearance of infused crystalloid fluid is very low during anaesthesia and surgery, but experiments in conscious sheep indicate that the renal fluid clearance might approach a normal rate when the adrenergic balance is modified.

METHODS Sixty females (mean age, 32 years) undergoing laparoscopic gynecological surgery were randomized to control group and received only the conventional anesthetic drugs and 20 ml/kg of lactated Ringer's over 30 min. The others were also given an infusion of 50 µg/kg/min of esmolol (beta1-receptor blocker) or 0.01 µg/kg/min of phenylephrine (alpha1-adrenergic agonist) over 3 hours. The distribution and elimination of infused fluid was studied by volume kinetic analysis based on urinary excretion and blood Hgb level.


Recruitment information / eligibility

Status Completed
Enrollment 60
Est. completion date October 2010
Est. primary completion date October 2010
Accepts healthy volunteers No
Gender Female
Age group 20 Years to 50 Years
Eligibility Inclusion Criteria:

- ASA group I

- Scheduled for laparoscopic removal of ovarian cyst or laparoscopic hysterectomy

Exclusion Criteria:

- ASA group > I

- Daily medication

Study Design

Allocation: Randomized, Endpoint Classification: Pharmacokinetics Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Caregiver), Primary Purpose: Supportive Care


Related Conditions & MeSH terms


Intervention

Drug:
Esmolol administration
50 µg/kg/min of the ß1-receptor-blocker esmolol was infused intravenous over 3 hours
Phenylephrine infusion
0.01 µg/kg/min of the alpha-1-adrenergic receptor agonist phenylephrine
Lactated Ringer´s solution
Intravenous Infusion of 10 ml/h lactated Ringer's solution that contained no drug

Locations

Country Name City State
China Department of Anesthesiology, First Affiliated Hospital, College of Medicine, Zhejiang University Hangzhou

Sponsors (2)

Lead Sponsor Collaborator
Sodertalje Hospital Zhejiang University

Country where clinical trial is conducted

China, 

References & Publications (4)

Ewaldsson CA, Vane LA, Kramer GC, Hahn RG. Adrenergic drugs alter both the fluid kinetics and the hemodynamic responses to volume expansion in sheep. J Surg Res. 2006 Mar;131(1):7-14. Epub 2005 Dec 2. — View Citation

Hahn RG. Volume kinetics for infusion fluids. Anesthesiology. 2010 Aug;113(2):470-81. doi: 10.1097/ALN.0b013e3181dcd88f. — View Citation

Olsson J, Svensén CH, Hahn RG. The volume kinetics of acetated Ringer's solution during laparoscopic cholecystectomy. Anesth Analg. 2004 Dec;99(6):1854-60, table of contents. — View Citation

Vane LA, Prough DS, Kinsky MA, Williams CA, Grady JJ, Kramer GC. Effects of different catecholamines on the dynamics of volume expansion of crystalloid infusion. Anesthesiology. 2004 Nov;101(5):1136-44. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Urinary excretion Urine was collected via an indwelling catheter during 3 hours of surgery 3 hours No
Secondary Volume kinetics of lactated Ringer´s solution Volume kinetics was analyzed based on serial analysis of the blood Hgb concentration and the collection of urine. Distribution between a central body and a peripheral body fluid space was then calculated over time. 3 hours No
See also
  Status Clinical Trial Phase
Terminated NCT02218502 - Study Into a New Diagnostic Tool (Simple Ultrasound-based Rules) in Patients With Adnexal Masses N/A
Completed NCT01937104 - ONSD According to the Position During Laparoscopy N/A
Completed NCT00746278 - A Random Clinical Trial (RCT) of the Impact of Electrocoagulation on Ovarian Reserve Phase 4
Recruiting NCT01631253 - The Impact on Ovarian Reserve After Single-port, Two-port, or Four-port Access Laparoscopic Ovarian Cyst Enucleation Phase 4
Not yet recruiting NCT05342298 - Assessment of Ovarian Cysts Using Machine Learning
Recruiting NCT02482467 - Prognosis and Long Term Pubertal Outcome of Girls Previously Diagnosed With a Prenatal Ovarian Cyst N/A
Completed NCT02835391 - PerClot Compared to Usual Care in Gynaecology Procedures N/A
Completed NCT01379313 - The Effect of Different I:E Ratio on Gas Exchange of Patients Undergoing Gynecologic Laparoscopic Surgery With Trendelenburg Position N/A
Completed NCT00222066 - Effect of Fetal Ovarian Cyst Aspiration to Prevent Torsion N/A
Completed NCT01288599 - Single Versus Conventional Laparoscopy for Benign Adnexal Disease Phase 3